• Explore /
  • Poster
  • / Phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced clear cell renal cell carcinoma (ccRCC).

Phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced clear cell renal cell carcinoma (ccRCC).

Abstract Poster

Authors

null

Robert J. Motzer

Memorial Sloan Kettering Cancer Center, New York, NY

Robert J. Motzer , Laurence Albiges , Toni K. Choueiri , Elizabeth R. Plimack , Brian I. Rini , Leah Suttner , Lina Yin , Jacqueline Willemann-Rogerio , Hans J. Hammers

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04626479; NCT04626518

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS404)

DOI

10.1200/JCO.2022.40.6_suppl.TPS404

Abstract #

TPS404

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Elizabeth R. Plimack

First Author: Toni K. Choueiri

First Author: Ken Kato

First Author: Laurence Albiges